157 related articles for article (PubMed ID: 32972440)
1. Bacterial infections in a pediatric cohort of primary and acquired complement deficiencies.
Al-Shaikhly T; Hayward K; Basiaga ML; Allenspach EJ
Pediatr Rheumatol Online J; 2020 Sep; 18(1):74. PubMed ID: 32972440
[TBL] [Abstract][Full Text] [Related]
2. Low complement levels in paediatric systemic lupus erythematosus and the risk of bacteraemia.
Hagen JP; Muller PC; Bredius RG; ten Cate R
BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23966458
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
4. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
[TBL] [Abstract][Full Text] [Related]
5. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP
Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
[TBL] [Abstract][Full Text] [Related]
6. Complete complement deficiency in a large cohort of familial systemic lupus erythematosus.
Aggarwal R; Sestak AL; D'Souza A; Dillon SP; Namjou B; Scofield RH
Lupus; 2010 Jan; 19(1):52-7. PubMed ID: 19910391
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for drug-resistant bloodstream infections in patients with systemic lupus erythematosus.
Barrera-Vargas A; Gómez-Martín D; Merayo-Chalico J; Ponce-de-León A; Alcocer-Varela J
J Rheumatol; 2014 Jul; 41(7):1311-6. PubMed ID: 24882843
[TBL] [Abstract][Full Text] [Related]
8. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
Verma J; Arora V; Marwaha V; Kumar A; Das N
Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
[TBL] [Abstract][Full Text] [Related]
9. Infections associated with juvenile systemic lupus erythematosus.
Al-Mayouf SM; Al-Jumaah S; Bahabri S; Al-Eid W
Clin Exp Rheumatol; 2001; 19(6):748-50. PubMed ID: 11791653
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal infection in patients with systemic lupus erythematosus.
Schurder J; Goulenok T; Jouenne R; Dossier A; Van Gysel D; Papo T; Sacre K
Joint Bone Spine; 2018 May; 85(3):333-336. PubMed ID: 28529115
[TBL] [Abstract][Full Text] [Related]
11. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus and infections: a retrospective study in Saudis.
Al-Rayes H; Al-Swailem R; Arfin M; Sobki S; Rizvi S; Tariq M
Lupus; 2007; 16(9):755-63. PubMed ID: 17728372
[TBL] [Abstract][Full Text] [Related]
13. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
Ho A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
[TBL] [Abstract][Full Text] [Related]
14. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study.
Merayo-Chalico J; Gómez-Martín D; Piñeirúa-Menéndez A; Santana-De Anda K; Alcocer-Varela J
QJM; 2013 May; 106(5):451-7. PubMed ID: 23458779
[TBL] [Abstract][Full Text] [Related]
15. Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups.
Mak A; Mok CC; Chu WP; To CH; Wong SN; Au TC
Lupus; 2007; 16(1):28-34. PubMed ID: 17283582
[TBL] [Abstract][Full Text] [Related]
16. High frequency of immunodeficiency-like states in systemic lupus erythematosus: a cross-sectional study in 300 consecutive patients.
Perazzio SF; Granados Á; Salomão R; Silva NP; Carneiro-Sampaio M; Andrade LE
Rheumatology (Oxford); 2016 Sep; 55(9):1647-55. PubMed ID: 27274095
[TBL] [Abstract][Full Text] [Related]
17. Cell-bound complement activation products associate with lupus severity in SLE.
Arriens C; Alexander RV; Narain S; Saxena A; Collins CE; Wallace DJ; Massarotti E; Conklin J; Kalunian KC; Putterman C; Ramsey-Goldman R; Buyon JP; Askanase A; Furie RA; James JA; Bello GA; Manzi S; Ahearn J; O'Malley T; Weinstein A; Dervieux T
Lupus Sci Med; 2020 Apr; 7(1):. PubMed ID: 32371480
[TBL] [Abstract][Full Text] [Related]
18. Hypogammaglobulinemia in pediatric systemic lupus erythematosus.
Lim E; Tao Y; White AJ; French AR; Cooper MA
Lupus; 2013 Nov; 22(13):1382-7. PubMed ID: 24106215
[TBL] [Abstract][Full Text] [Related]
19. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
Cohen S; Clowse M; Pardo P; Bhattacharya I; Menon S; Gourley I; Diehl A
Clin Ther; 2016 Jun; 38(6):1417-1434.e2. PubMed ID: 27112532
[TBL] [Abstract][Full Text] [Related]
20. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]